The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Brainstorm Cell Therapeutics Inc(NASDAQ:BCLI) 
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company holds rights to develop and commercialize its NurOwn technology that utilizes cell culture method...
Website: http://www.brainstorm-cell.com
Founded: 2000
Full Time Employees: 44
Sector: Healthcare
Industry: Biotechnology
Brainstorm Cell Therapeutics Days Payable Outstanding ttm (DPO)
Brainstorm Cell Therapeutics Days Receivable Outstanding ttm (DSO)
Brainstorm Cell Therapeutics Op Cashflow Per Share ttm
Brainstorm Cell Therapeutics Free Cashflow Per Share ttm
Brainstorm Cell Therapeutics Cash Per Share ttm
Brainstorm Cell Therapeutics P/S ratio ttm
Brainstorm Cell Therapeutics (GAAP) P/E ratio ttm
Brainstorm Cell Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.